Praxis Precision Medicines PRAX

$ 76.99 5.7%

Quarterly report 2024-Q3
added 11-06-2024

Praxis Precision Medicines Balance Sheet 2011-2024 | PRAX

Annual Balance Sheet Praxis Precision Medicines

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-78.8 M	-58.1 M	-134 M	-296 M	-43.4 M	-18 M	-	-	-	-	-	-	-
Long Term Debt	1.37 M	2.5 M	3.5 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	1.13 M	1 M	810 K	763 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	122 M	55.7 M	-	-	-	-	-	-	-
Total Current Liabilities	15.7 M	34.3 M	38.4 M	15.7 M	-	-	-	-	-	-	-	-	-
Total Liabilities	18.3 M	39 M	41.9 M	15.7 M	129 M	60.9 M	-	-	-	-	-	-	-
Deferred Revenue	1.39 M	2.82 M	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-654 M	-531 M	-317 M	-150 M	-81 M	-41.4 M	-	-	-	-	-	-	-
Total Assets	87.9 M	115 M	293 M	303 M	47.7 M	19.8 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	81.3 M	61.6 M	139 M	297 M	45.4 M	-	-	-	-	-	-	-	-
Book Value	69.7 M	76.1 M	251 M	287 M	-81 M	-41 M	-	-	-	-	-	-	-
Total Shareholders Equity	69.7 M	76.1 M	251 M	287 M	-81 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Praxis Precision Medicines

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	436 K	755 K	1.07 M	1.37 M	1.66 M	1.95 M	2.22 M	2.5 M	2.76 M	3.01 M	3.26 M	3.5 M	3.73 M	3.96 M	-	-	-	-	-	763 K	763 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	33.6 M	22 M	20.7 M	18.3 M	20 M	27.9 M	33.9 M	39 M	31.7 M	41.5 M	48.5 M	41.9 M	28.5 M	19.7 M	13.7 M	15.7 M	15.7 M	15.7 M	15.7 M	7.58 M	7.58 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	1.17 M	1.18 M	1.26 M	1.39 M	1.55 M	2.04 M	2.54 M	2.82 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-778 M	-726 M	-693 M	-654 M	-627 M	-602 M	-568 M	-531 M	-489 M	-446 M	-385 M	-317 M	-258 M	-213 M	-177 M	-150 M	-150 M	-150 M	-150 M	-81 M	-81 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	416 M	441 M	250 M	87.9 M	107 M	133 M	98.4 M	115 M	137 M	180 M	240 M	293 M	324 M	354 M	279 M	303 M	303 M	303 M	303 M	47.7 M	47.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	169 M	145 M	152 M	81.3 M	101 M	124 M	80.8 M	61.6 M	62.4 M	56 M	77.9 M	139 M	166 M	176 M	131 M	297 M	297 M	297 M	297 M	44.8 M	44.8 M	-	-	18.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	383 M	419 M	230 M	69.7 M	86.8 M	106 M	64.5 M	76.1 M	105 M	139 M	191 M	251 M	296 M	334 M	266 M	287 M	287 M	287 M	287 M	40.1 M	40.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	383 M	419 M	230 M	69.7 M	86.8 M	106 M	64.5 M	76.1 M	105 M	139 M	191 M	251 M	296 M	334 M	266 M	287 M	287 M	287 M	287 M	-81 M	-81 M	-60.5 M	-	-41 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency